This section gives some more detailed guidance around the issues to consider in the early stage of a company’s operations.

GNX 12: Getting your voice heard by big pharma
GNP 5: Unified Patent Court and Unitary Patent in Europe
GNP 4: Patent Filing Strategies
GNP 3: Pros and Cons of Filing a Patent
GNP 2: Patent Fundamentals
GNP 1: Intellectual Property Basics
GNT 72: Tax treatment of interest on convertible loans
GNT 71: Corporate Interest Restriction (CIR)
GNT 70: Working from Home (in the UK and abroad) – Common Tax Concerns
GNT 69: Making Tax Digital for Corporation Tax
GNT 68: Making Tax Digital for VAT
GNT 67: Non-resident directors
GNT 65: A tax overview of share schemes and other equity incentives
GNT 64: Off payroll workers : IR35 for the private sector from April 2021
GNT 57: Trading Company Status
GNT 58: Corporate Criminal Offence – As Applied to Life Sciences
GNT 54: PAYE Settlement Agreements (PSAs)
GNT 40: EMI Valuations
GNT 10: EMI Share Options
GNT 31: SME R&D Tax Credit and RDEC Comparison
GNT 27: SME R&D Regime Essentials
GNT 38: Bioscience Explained to Support Tax Returns
GNT 17: Compliance Essentials
GNT 9: Compliance Best Practice for Development Companies


Essential insight ahead of private fundraising.

Sign-Up For Free

Sign-up to receive up-to-date information and advice on tax developments within your industry.

Sign-up for free